In its latest SEC filing for the third quarter, Generali Asset Management SPA SGR reduced its position in Target Corporation by 35.6%, selling 18,630 shares and retaining 33,721 shares valued at approximately $3.03 million. This reduction follows a broader shift among institutional holders: while Generali’s stake dropped to represent 0.007% of the company’s outstanding shares, Vanguard Group increased its holding by 14.7% to over 51.4 million shares, and Kingstone Capital, Norges Bank and Arrowstreet Capital each established or expanded positions totaling nearly $1.4 billion combined.

Also in Q3, Diversified Trust Co trimmed its holdings in Target by 44.9%, selling 5,769 shares and ending the period with 7,076 shares worth roughly $635,000. Other wealth managers followed diverse strategies: Brighton Jones more than doubled its position to 6,080 shares in Q4, EP Wealth Advisors and AlTi Global added modest stakes in Q1, and AQR Capital Management increased its holding to 761,621 shares, underscoring the range of institutional conviction in Target’s long-term outlook.

On November 19th, Target reported third-quarter EPS of $1.78, $0.07 above consensus, and revenue of $25.27 billion, marginally below forecasts. Net margin stood at 3.58% with return on equity of 22.74%, compared to $1.85 EPS and 1.6% higher revenue a year earlier. Management set fiscal 2025 EPS guidance at a range of 7.00 to 8.00, while analysts project 8.69 EPS for the year. Ten analysts maintain Buy ratings, 22 Hold and four Sell, yielding an average consensus price target of $102.66, signaling neutrality but highlighting potential upside if operational initiatives accelerate sales growth.